THE Therapeutic Goods Administration (TGA) has released its latest analysis of adverse event (AE) reports, covering about 18,600 incidents during 2017.
The majority of reports made last year were by sponsors, at a new high of 9,998 or 54%.
The previous highest reported number was in 2013 (9,563) while its lowest point for this five-year period was in 2014 (8,359).
Of the total adverse event reports, 18% (3,441) were from state and territory health departments (reports of adverse events following immunisation); 10% (1,879) came from hospitals and hospital pharmacists; 7% (1,201) from consumers; 6% (1,170) from community pharmacists; 3% (579) from general practitioners and 2% (359) from other sources.
Compared to previous years, the biggest increases in reports of adverse events were from sponsors and state and territory health departments.
The TGA said the increase in reports from health departments may relate in part, to the continuation of enhanced surveillance for two additions to the National Immunisation Program in 2016, namely the 18-month diphtheria, tetanus and acellular pertussis-containing vaccine and Zostavax.
Find more data at tga.gov.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 13 Aug 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 13 Aug 18
